| Shrunjal Patel, | |
|
3901 Rainbow Blvd, Kansas City, KS 66160-8500 | |
| (913) 588-6670 | |
| Not Available |
| Full Name | Shrunjal Patel |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 7 Years |
| Location | 3901 Rainbow Blvd, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528592326 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 43557496081 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tucson Medical Center | Tucson, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ias Arizona Pllc | 7517312648 | 145 |
News Archive
For the second time in less than one month, the University of Medicine and Dentistry of New Jersey-New Jersey Medical School has been awarded a coveted $15 million grant by the National Institutes of Health.
Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
An international gathering of researchers from 19 countries has agreed for the first time to establish uniform measurement standards for antioxidants.
The federal government's systems for analyzing Medicare and Medicaid data for possible fraud are inadequate and underused, making it more difficult to detect the billions of dollars in fraudulent claims paid out each year, according to a report released Tuesday.
As innovation expands the accessibility of technology, the potential for distraction increases as well. A new assesses the level and type of distractions that affect mothers during infant feeding and discusses the potential impact on mothers and babies.
› Verified 5 days ago
| Entity Name | Banner -- University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508809427 PECOS PAC ID: 7719899871 Enrollment ID: O20031105000694 |
News Archive
For the second time in less than one month, the University of Medicine and Dentistry of New Jersey-New Jersey Medical School has been awarded a coveted $15 million grant by the National Institutes of Health.
Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
An international gathering of researchers from 19 countries has agreed for the first time to establish uniform measurement standards for antioxidants.
The federal government's systems for analyzing Medicare and Medicaid data for possible fraud are inadequate and underused, making it more difficult to detect the billions of dollars in fraudulent claims paid out each year, according to a report released Tuesday.
As innovation expands the accessibility of technology, the potential for distraction increases as well. A new assesses the level and type of distractions that affect mothers during infant feeding and discusses the potential impact on mothers and babies.
› Verified 5 days ago
| Entity Name | Ias Arizona Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689359747 PECOS PAC ID: 7517312648 Enrollment ID: O20231010003129 |
News Archive
For the second time in less than one month, the University of Medicine and Dentistry of New Jersey-New Jersey Medical School has been awarded a coveted $15 million grant by the National Institutes of Health.
Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
An international gathering of researchers from 19 countries has agreed for the first time to establish uniform measurement standards for antioxidants.
The federal government's systems for analyzing Medicare and Medicaid data for possible fraud are inadequate and underused, making it more difficult to detect the billions of dollars in fraudulent claims paid out each year, according to a report released Tuesday.
As innovation expands the accessibility of technology, the potential for distraction increases as well. A new assesses the level and type of distractions that affect mothers during infant feeding and discusses the potential impact on mothers and babies.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shrunjal Patel, 3901 Rainbow Blvd, Kansas City, KS 66160-8500 Ph: (913) 588-6670 | Shrunjal Patel, 3901 Rainbow Blvd, Kansas City, KS 66160-8500 Ph: (913) 588-6670 |
News Archive
For the second time in less than one month, the University of Medicine and Dentistry of New Jersey-New Jersey Medical School has been awarded a coveted $15 million grant by the National Institutes of Health.
Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
An international gathering of researchers from 19 countries has agreed for the first time to establish uniform measurement standards for antioxidants.
The federal government's systems for analyzing Medicare and Medicaid data for possible fraud are inadequate and underused, making it more difficult to detect the billions of dollars in fraudulent claims paid out each year, according to a report released Tuesday.
As innovation expands the accessibility of technology, the potential for distraction increases as well. A new assesses the level and type of distractions that affect mothers during infant feeding and discusses the potential impact on mothers and babies.
› Verified 5 days ago
Mrs. Michelle Renee Altenhofen, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5000 | |
Nicki L Hamilton, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6670 Fax: 212-263-0664 | |
Renee L Mauer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6670 Fax: 913-588-3365 | |
Morgan Bassi, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5000 | |
Kami Lynn Craigg, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St, Kansas City, KS 66160 Phone: 913-588-1227 | |
John Wade Fogarty, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St, Kansas City, KS 66160 Phone: 913-588-1200 | |
Trevor Mason, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St, Kansas City, KS 66160 Phone: 913-424-2635 |